Exact Mass: 461.242
Exact Mass Matches: 461.242
Found 500 metabolites which its exact mass value is equals to given mass value 461.242
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Pimozide
A diphenylbutylpiperidine that is effective as an antipsychotic agent and as an alternative to haloperidol for the suppression of vocal and motor tics in patients with Tourette syndrome. Although the precise mechanism of action is unknown, blockade of postsynaptic dopamine receptors has been postulated. (From AMA Drug Evaluations Annual, 1994, p403) D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014150 - Antipsychotic Agents N - Nervous system > N05 - Psycholeptics > N05A - Antipsychotics > N05AG - Diphenylbutylpiperidine derivatives D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents > D018492 - Dopamine Antagonists D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials D002491 - Central Nervous System Agents > D018726 - Anti-Dyskinesia Agents C78272 - Agent Affecting Nervous System > C29710 - Antipsychotic Agent Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS Pimozide is a dopamine receptor antagonist, with Kis of 1.4 nM, 2.5 nM and 588 nM for dopamine D2, D3 and D1 receptors, respectively, and also has affinity at α1-adrenoceptor, with a Ki of 39 nM; Pimozide also inhibits STAT3 and STAT5.
plumbagine E alpha-D-xylopyranoside|plumbagoside B
Ser Lys Val Glu
Thr Val Asp Lys
Val Glu Ser Lys
pimozide
D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014150 - Antipsychotic Agents N - Nervous system > N05 - Psycholeptics > N05A - Antipsychotics > N05AG - Diphenylbutylpiperidine derivatives D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents > D018492 - Dopamine Antagonists D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials D002491 - Central Nervous System Agents > D018726 - Anti-Dyskinesia Agents C78272 - Agent Affecting Nervous System > C29710 - Antipsychotic Agent Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS CONFIDENCE standard compound; INTERNAL_ID 205; DATASET 20200303_ENTACT_RP_MIX501; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3862; ORIGINAL_PRECURSOR_SCAN_NO 3860 CONFIDENCE standard compound; INTERNAL_ID 205; DATASET 20200303_ENTACT_RP_MIX501; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3823; ORIGINAL_PRECURSOR_SCAN_NO 3820 CONFIDENCE standard compound; INTERNAL_ID 205; DATASET 20200303_ENTACT_RP_MIX501; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3854; ORIGINAL_PRECURSOR_SCAN_NO 3850 CONFIDENCE standard compound; INTERNAL_ID 205; DATASET 20200303_ENTACT_RP_MIX501; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8187; ORIGINAL_PRECURSOR_SCAN_NO 8184 CONFIDENCE standard compound; INTERNAL_ID 205; DATASET 20200303_ENTACT_RP_MIX501; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8258; ORIGINAL_PRECURSOR_SCAN_NO 8257 CONFIDENCE standard compound; INTERNAL_ID 205; DATASET 20200303_ENTACT_RP_MIX501; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8218; ORIGINAL_PRECURSOR_SCAN_NO 8216 CONFIDENCE standard compound; INTERNAL_ID 205; DATASET 20200303_ENTACT_RP_MIX501; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8255; ORIGINAL_PRECURSOR_SCAN_NO 8253 CONFIDENCE standard compound; INTERNAL_ID 205; DATASET 20200303_ENTACT_RP_MIX501; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8237; ORIGINAL_PRECURSOR_SCAN_NO 8235 CONFIDENCE standard compound; INTERNAL_ID 205; DATASET 20200303_ENTACT_RP_MIX501; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8257; ORIGINAL_PRECURSOR_SCAN_NO 8255 Pimozide is a dopamine receptor antagonist, with Kis of 1.4 nM, 2.5 nM and 588 nM for dopamine D2, D3 and D1 receptors, respectively, and also has affinity at α1-adrenoceptor, with a Ki of 39 nM; Pimozide also inhibits STAT3 and STAT5.
Ala Cys Ile Arg
Ala Cys Leu Arg
Ala Cys Arg Ile
Ala Cys Arg Leu
Ala Ile Cys Arg
Ala Ile Met Gln
Ala Ile Gln Met
Ala Ile Arg Cys
Ala Leu Cys Arg
Ala Leu Met Gln
Ala Leu Gln Met
Ala Leu Arg Cys
Ala Met Ile Gln
Ala Met Leu Gln
Ala Met Gln Ile
Ala Met Gln Leu
Ala Gln Ile Met
Ala Gln Leu Met
Ala Gln Met Ile
Ala Gln Met Leu
Ala Arg Cys Ile
Ala Arg Cys Leu
Ala Arg Ile Cys
Ala Arg Leu Cys
Cys Ala Ile Arg
Cys Ala Leu Arg
Cys Ala Arg Ile
Cys Ala Arg Leu
Cys Ile Ala Arg
Cys Ile Ile Asn
Cys Ile Leu Asn
Cys Ile Asn Ile
Cys Ile Asn Leu
Cys Ile Gln Val
Cys Ile Arg Ala
Cys Ile Val Gln
Cys Leu Ala Arg
Cys Leu Ile Asn
Cys Leu Leu Asn
Cys Leu Asn Ile
Cys Leu Asn Leu
Cys Leu Gln Val
Cys Leu Arg Ala
Cys Leu Val Gln
Cys Asn Ile Ile
Cys Asn Ile Leu
Cys Asn Leu Ile
Cys Asn Leu Leu
Cys Gln Ile Val
Cys Gln Leu Val
Cys Gln Val Ile
Cys Gln Val Leu
Cys Arg Ala Ile
Cys Arg Ala Leu
Cys Arg Ile Ala
Cys Arg Leu Ala
Cys Val Ile Gln
Cys Val Leu Gln
Cys Val Gln Ile
Cys Val Gln Leu
Asp Ile Lys Ser
Asp Ile Ser Lys
Asp Lys Ile Ser
Asp Lys Leu Ser
Asp Lys Ser Ile
Asp Lys Ser Leu
Asp Lys Thr Val
Asp Lys Val Thr
Asp Leu Lys Ser
Asp Leu Ser Lys
Asp Ser Ile Lys
Asp Ser Lys Ile
Asp Ser Lys Leu
Asp Ser Leu Lys
Asp Thr Lys Val
Asp Thr Val Lys
Asp Val Lys Thr
Asp Val Thr Lys
Glu Lys Ser Val
Glu Lys Val Ser
Glu Ser Lys Val
Glu Ser Val Lys
Glu Val Lys Ser
Glu Val Ser Lys
Gly Met Arg Val
Gly Met Val Arg
Gly Arg Met Val
Gly Arg Val Met
Gly Val Met Arg
Gly Val Arg Met
Gly Trp Val Thr
Ile Ala Cys Arg
Ile Ala Met Gln
Ile Ala Gln Met
Ile Ala Arg Cys
Ile Cys Ala Arg
Ile Cys Ile Asn
Ile Cys Leu Asn
Ile Cys Asn Ile
Ile Cys Asn Leu
Ile Cys Gln Val
Ile Cys Arg Ala
Ile Cys Val Gln
Ile Asp Lys Ser
Ile Asp Ser Lys
Ile Ile Cys Asn
Ile Ile Asn Cys
Ile Lys Asp Ser
Ile Lys Ser Asp
Ile Leu Cys Asn
Ile Leu Asn Cys
Ile Met Ala Gln
Ile Met Gln Ala
Ile Asn Cys Ile
Ile Asn Cys Leu
Ile Asn Ile Cys
Ile Asn Leu Cys
Ile Gln Ala Met
Ile Gln Cys Val
Ile Gln Met Ala
Ile Gln Thr Thr
Ile Gln Val Cys
Ile Arg Ala Cys
Ile Arg Cys Ala
Ile Ser Asp Lys
Ile Ser Lys Asp
Ile Thr Gln Thr
Ile Thr Thr Gln
Ile Val Cys Gln
Ile Val Gln Cys
Lys Asp Ile Ser
Lys Asp Leu Ser
Lys Asp Ser Ile
Lys Asp Ser Leu
Lys Asp Thr Val
Lys Asp Val Thr
Lys Glu Ser Val
Lys Glu Val Ser
Lys Ile Asp Ser
Lys Ile Ser Asp
Lys Leu Asp Ser
Lys Leu Ser Asp
Lys Met Pro Ser
Lys Met Ser Pro
Lys Pro Met Ser
Lys Pro Ser Met
Lys Ser Asp Ile
Lys Ser Asp Leu
Lys Ser Glu Val
Lys Ser Ile Asp
Lys Ser Leu Asp
Lys Ser Met Pro
Lys Ser Pro Met
Lys Ser Val Glu
Lys Thr Asp Val
Lys Thr Val Asp
Lys Val Asp Thr
Lys Val Glu Ser
Lys Val Ser Glu
Lys Val Thr Asp
Leu Ala Cys Arg
Leu Ala Met Gln
Leu Ala Gln Met
Leu Ala Arg Cys
Leu Cys Ala Arg
Leu Cys Ile Asn
Leu Cys Leu Asn
Leu Cys Asn Ile
Leu Cys Asn Leu
Leu Cys Gln Val
Leu Cys Arg Ala
Leu Cys Val Gln
Leu Asp Lys Ser
Leu Asp Ser Lys
Leu Ile Cys Asn
Leu Ile Asn Cys
Leu Lys Asp Ser
Leu Lys Ser Asp
Leu Leu Cys Asn
Leu Leu Asn Cys
Leu Met Ala Gln
Leu Met Gln Ala
Leu Asn Cys Ile
Leu Asn Cys Leu
Leu Asn Ile Cys
Leu Asn Leu Cys
Leu Gln Ala Met
Leu Gln Cys Val
Leu Gln Met Ala
Leu Gln Thr Thr
Leu Gln Val Cys
Leu Arg Ala Cys
Leu Arg Cys Ala
Leu Ser Asp Lys
Leu Ser Lys Asp
Leu Thr Gln Thr
Leu Thr Thr Gln
Leu Val Cys Gln
Leu Val Gln Cys
Met Ala Ile Gln
Met Ala Leu Gln
Met Ala Gln Ile
Met Ala Gln Leu
Met Gly Arg Val
Met Gly Val Arg
Met Ile Ala Gln
Met Ile Gln Ala
Met Lys Pro Ser
Met Lys Ser Pro
Met Leu Ala Gln
Met Leu Gln Ala
Met Asn Val Val
Met Pro Lys Ser
Met Pro Ser Lys
Met Gln Ala Ile
Met Gln Ala Leu
Met Gln Ile Ala
Met Gln Leu Ala
Met Arg Gly Val
Met Arg Val Gly
Met Ser Lys Pro
Met Ser Pro Lys
Met Val Gly Arg
Met Val Asn Val
Met Val Arg Gly
Met Val Val Asn
Asn Cys Ile Ile
Asn Cys Ile Leu
Asn Cys Leu Ile
Asn Cys Leu Leu
Asn Ile Cys Ile
Asn Ile Cys Leu
Asn Ile Ile Cys
Asn Ile Leu Cys
Asn Leu Cys Ile
Asn Leu Cys Leu
Asn Leu Ile Cys
Asn Leu Leu Cys
Asn Met Val Val
Asn Val Met Val
Asn Val Val Met
Pro Lys Met Ser
Pro Lys Ser Met
Pro Met Lys Ser
Pro Met Ser Lys
Pro Ser Lys Met
Pro Ser Met Lys
Gln Ala Ile Met
Gln Ala Leu Met
Gln Ala Met Ile
Gln Ala Met Leu
Gln Cys Ile Val
Gln Cys Leu Val
Gln Cys Val Ile
Gln Cys Val Leu
Gln Ile Ala Met
Gln Ile Cys Val
Gln Ile Met Ala
Gln Ile Thr Thr
Gln Ile Val Cys
Gln Leu Ala Met
Gln Leu Cys Val
Gln Leu Met Ala
Gln Leu Thr Thr
Gln Leu Val Cys
Gln Met Ala Ile
Gln Met Ala Leu
Gln Met Ile Ala
Gln Met Leu Ala
Gln Thr Ile Thr
Gln Thr Leu Thr
Gln Thr Thr Ile
Gln Thr Thr Leu
Gln Val Cys Ile
Gln Val Cys Leu
Gln Val Ile Cys
Gln Val Leu Cys
Arg Ala Cys Ile
Arg Ala Cys Leu
Arg Ala Ile Cys
Arg Ala Leu Cys
Arg Cys Ala Ile
Arg Cys Ala Leu
Arg Cys Ile Ala
Arg Cys Leu Ala
Arg Gly Met Val
Arg Gly Val Met
Arg Ile Ala Cys
Arg Ile Cys Ala
Arg Leu Ala Cys
Arg Leu Cys Ala
Arg Met Gly Val
Arg Met Val Gly
Arg Val Gly Met
Arg Val Met Gly
Ser Asp Ile Lys
Ser Asp Lys Ile
Ser Asp Lys Leu
Ser Asp Leu Lys
Ser Glu Lys Val
Ser Glu Val Lys
Ser Ile Asp Lys
Ser Ile Lys Asp
Ser Lys Asp Ile
Ser Lys Asp Leu
Ser Lys Glu Val
Ser Lys Ile Asp
Ser Lys Leu Asp
Ser Lys Met Pro
Ser Lys Pro Met
Ser Leu Asp Lys
Ser Leu Lys Asp
Ser Met Lys Pro
Ser Met Pro Lys
Ser Pro Lys Met
Ser Pro Met Lys
Ser Val Glu Lys
Ser Val Lys Glu
Ser Trp Gly Ile
Thr Asp Lys Val
Thr Asp Val Lys
Thr Ile Gln Thr
Thr Ile Thr Gln
Thr Lys Asp Val
Thr Lys Val Asp
Thr Leu Gln Thr
Thr Leu Thr Gln
Thr Gln Ile Thr
Thr Gln Leu Thr
Thr Gln Thr Ile
Thr Gln Thr Leu
Thr Thr Ile Gln
Thr Thr Leu Gln
Thr Thr Gln Ile
Thr Thr Gln Leu
Thr Val Lys Asp
Val Cys Ile Gln
Val Cys Leu Gln
Val Cys Gln Ile
Val Cys Gln Leu
Val Asp Lys Thr
Val Asp Thr Lys
Val Glu Lys Ser
Val Gly Met Arg
Val Gly Arg Met
Val Ile Cys Gln
Val Ile Gln Cys
Val Lys Asp Thr
Val Lys Glu Ser
Val Lys Ser Glu
Val Lys Thr Asp
Val Leu Cys Gln
Val Leu Gln Cys
Val Met Gly Arg
Val Met Asn Val
Val Met Arg Gly
Val Met Val Asn
Val Asn Met Val
Val Asn Val Met
Val Gln Cys Ile
Val Gln Cys Leu
Val Gln Ile Cys
Val Gln Leu Cys
Val Arg Gly Met
Val Arg Met Gly
Val Ser Glu Lys
Val Ser Lys Glu
Val Thr Asp Lys
Val Thr Lys Asp
Val Val Met Asn
Val Val Asn Met
Val Trp Ala Ser
Val Trp Gly Thr
Val Trp Ser Ala
Val Trp Thr Gly
Trp Ala Ser Val
Trp Ala Val Ser
Trp Gly Ile Ser
Trp Gly Leu Ser
Trp Gly Ser Ile
Trp Gly Ser Leu
Trp Gly Thr Val
Trp Gly Val Thr
Trp Ile Gly Ser
Trp Ile Ser Gly
Trp Leu Gly Ser
Trp Leu Ser Gly
Trp Ser Ala Val
1-[[pentanoyl-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]amino]methyl]cyclopentane-1-carboxylic acid
(9R)-9-[[3,6-Dideoxy-4-O-(1H-indol-3-ylcarbonyl)-alpha-L-arabino-hexopyranosyl]oxy]decanoic acid
10-[[3,6-Dideoxy-4-O-(1H-indol-3-ylcarbonyl)-alpha-L-arabino-hexopyranosyl]oxy]decanoic acid
4-[(6,7-diethoxy-2,4-dioxo-1H-quinazolin-3-yl)methyl]-N-(3-methoxypropyl)-1-cyclohexanecarboxamide
4-[4-[(6S,7R,8R)-4-(2-cyclopropyl-1-oxoethyl)-8-(hydroxymethyl)-2-oxo-1,4-diazabicyclo[4.2.0]octan-7-yl]phenyl]-N,N-dimethylbenzamide
2-[(1R,3R,4aR,9aS)-1-(hydroxymethyl)-6-[(2-methoxy-1-oxoethyl)amino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-[2-(1-piperidinyl)ethyl]acetamide
2-[(1R,3S,4aR,9aS)-1-(hydroxymethyl)-6-[(2-methoxy-1-oxoethyl)amino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-[2-(1-piperidinyl)ethyl]acetamide
2-[(1S,3S,4aR,9aS)-1-(hydroxymethyl)-6-[(2-methoxy-1-oxoethyl)amino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-[2-(1-piperidinyl)ethyl]acetamide
2-[(1S,3R,4aR,9aS)-1-(hydroxymethyl)-6-[(2-methoxy-1-oxoethyl)amino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-[2-(1-piperidinyl)ethyl]acetamide
(6R,7R,8R)-7-[4-(1-cyclohexenyl)phenyl]-8-(hydroxymethyl)-N-(3-methoxyphenyl)-2-oxo-1,4-diazabicyclo[4.2.0]octane-4-carboxamide
(6S,7S,8S)-7-[4-(1-cyclohexenyl)phenyl]-8-(hydroxymethyl)-N-(3-methoxyphenyl)-2-oxo-1,4-diazabicyclo[4.2.0]octane-4-carboxamide
cyclopropyl-[(1S)-1-(hydroxymethyl)-7-methoxy-1-[(3-methoxyphenyl)methyl]-2-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,3-azetidine]yl]methanone
4-[4-[(6R,7R,8S)-4-(2-cyclopropyl-1-oxoethyl)-8-(hydroxymethyl)-2-oxo-1,4-diazabicyclo[4.2.0]octan-7-yl]phenyl]-N,N-dimethylbenzamide
3-[4-[(6S,7S,8R)-4-[cyclobutyl(oxo)methyl]-8-(hydroxymethyl)-2-oxo-1,4-diazabicyclo[4.2.0]octan-7-yl]phenyl]-N,N-dimethylbenzamide
3-[4-[(6S,7R,8R)-4-[cyclobutyl(oxo)methyl]-8-(hydroxymethyl)-2-oxo-1,4-diazabicyclo[4.2.0]octan-7-yl]phenyl]-N,N-dimethylbenzamide
2-[(1S,3S,4aS,9aR)-1-(hydroxymethyl)-6-[(2-methoxy-1-oxoethyl)amino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-[2-(1-piperidinyl)ethyl]acetamide
2-[(1S,3R,4aS,9aR)-1-(hydroxymethyl)-6-[(2-methoxy-1-oxoethyl)amino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-[2-(1-piperidinyl)ethyl]acetamide
2-[(1R,3R,4aS,9aR)-1-(hydroxymethyl)-6-[(2-methoxy-1-oxoethyl)amino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-[2-(1-piperidinyl)ethyl]acetamide
2-[(1R,3S,4aS,9aR)-1-(hydroxymethyl)-6-[(2-methoxy-1-oxoethyl)amino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-[2-(1-piperidinyl)ethyl]acetamide
(6R,7R,8S)-7-[4-(1-cyclohexenyl)phenyl]-8-(hydroxymethyl)-N-(3-methoxyphenyl)-2-oxo-1,4-diazabicyclo[4.2.0]octane-4-carboxamide
(6S,7S,8R)-7-[4-(1-cyclohexenyl)phenyl]-8-(hydroxymethyl)-N-(3-methoxyphenyl)-2-oxo-1,4-diazabicyclo[4.2.0]octane-4-carboxamide
[(1R)-1-(cyclopentylmethyl)-7-methoxy-2-methylsulfonyl-1-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,4-piperidine]yl]methanol
[(1S)-1-(cyclopentylmethyl)-7-methoxy-2-methylsulfonyl-1-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,4-piperidine]yl]methanol
cyclopropyl-[(1R)-1-(hydroxymethyl)-7-methoxy-1-[(3-methoxyphenyl)methyl]-2-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,3-azetidine]yl]methanone
4-[4-[(6S,7S,8S)-4-(2-cyclopropyl-1-oxoethyl)-8-(hydroxymethyl)-2-oxo-1,4-diazabicyclo[4.2.0]octan-7-yl]phenyl]-N,N-dimethylbenzamide
4-[4-[(6S,7S,8R)-4-(2-cyclopropyl-1-oxoethyl)-8-(hydroxymethyl)-2-oxo-1,4-diazabicyclo[4.2.0]octan-7-yl]phenyl]-N,N-dimethylbenzamide
4-[4-[(6R,7S,8S)-4-(2-cyclopropyl-1-oxoethyl)-8-(hydroxymethyl)-2-oxo-1,4-diazabicyclo[4.2.0]octan-7-yl]phenyl]-N,N-dimethylbenzamide
4-[4-[(6R,7R,8R)-4-(2-cyclopropyl-1-oxoethyl)-8-(hydroxymethyl)-2-oxo-1,4-diazabicyclo[4.2.0]octan-7-yl]phenyl]-N,N-dimethylbenzamide
3-[4-[(6R,7S,8S)-4-[cyclobutyl(oxo)methyl]-8-(hydroxymethyl)-2-oxo-1,4-diazabicyclo[4.2.0]octan-7-yl]phenyl]-N,N-dimethylbenzamide
3-[4-[(6R,7R,8S)-4-[cyclobutyl(oxo)methyl]-8-(hydroxymethyl)-2-oxo-1,4-diazabicyclo[4.2.0]octan-7-yl]phenyl]-N,N-dimethylbenzamide
3-[4-[(6R,7S,8R)-4-[cyclobutyl(oxo)methyl]-8-(hydroxymethyl)-2-oxo-1,4-diazabicyclo[4.2.0]octan-7-yl]phenyl]-N,N-dimethylbenzamide
3-[4-[(6R,7R,8R)-4-[cyclobutyl(oxo)methyl]-8-(hydroxymethyl)-2-oxo-1,4-diazabicyclo[4.2.0]octan-7-yl]phenyl]-N,N-dimethylbenzamide
(1s,2s,17s,19r)-26-hydroxy-2-methoxy-9,9,16,16-tetramethyl-8-oxa-14,23,25-triazaheptacyclo[17.5.2.0¹,¹⁷.0³,¹⁵.0⁴,¹³.0⁷,¹².0¹⁹,²³]hexacosa-3(15),4,6,10,12,25-hexaen-24-one
(2s,3as,6r,7as)-1-[(2s,3r)-2-{[(2r)-1,2-dihydroxy-3-(4-hydroxyphenyl)propylidene]amino}-3-methylpentanoyl]-6-hydroxy-octahydroindole-2-carboximidic acid
26-hydroxy-2-methoxy-9,9,16,16-tetramethyl-8-oxa-14,23,25-triazaheptacyclo[17.5.2.0¹,¹⁷.0³,¹⁵.0⁴,¹³.0⁷,¹².0¹⁹,²³]hexacosa-3(15),4,6,10,12,25-hexaen-24-one
(2s)-n-[(4e,6e,8s,10e,12e,14s,16r,20r)-8,14-dihydroxy-5,11,19,20-tetramethyl-18-oxo-2,17-dioxabicyclo[14.3.1]icosa-1(19),4,6,10,12-pentaen-3-yl]-2-hydroxypropanimidic acid
(1s,9ar)-octahydro-1h-quinolizin-1-ylmethyl (2e)-3-(4-{[(2r,3s,4s,5s,6r)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}phenyl)prop-2-enoate
1-(2-{[1,2-dihydroxy-3-(4-hydroxyphenyl)propylidene]amino}-4-methylpentanoyl)-6-hydroxy-octahydroindole-2-carboximidic acid
(2s,3as,6r,7as)-1-[(2r)-2-{[(2r)-1,2-dihydroxy-3-(4-hydroxyphenyl)propylidene]amino}-4-methylpentanoyl]-6-hydroxy-octahydroindole-2-carboximidic acid
(1s,9ar)-octahydro-1h-quinolizin-1-ylmethyl (2e)-3-(4-{[(2s,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}phenyl)prop-2-enoate
(1s,2r,17r,19r)-26-hydroxy-2-methoxy-9,9,16,16-tetramethyl-8-oxa-14,23,25-triazaheptacyclo[17.5.2.0¹,¹⁷.0³,¹⁵.0⁴,¹³.0⁷,¹².0¹⁹,²³]hexacosa-3(15),4,6,10,12,25-hexaen-24-one
(1s,9ar)-octahydro-1h-quinolizin-1-ylmethyl (2z)-3-(4-{[(2r,3s,4s,5s,6r)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}phenyl)prop-2-enoate
octahydro-1h-quinolizin-1-ylmethyl 3-{4-[(3,4,5-trihydroxy-6-methyloxan-2-yl)oxy]phenyl}prop-2-enoate
(1s,9ar)-octahydro-1h-quinolizin-1-ylmethyl (2e)-3-(4-{[(2s,3s,4s,5r,6r)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}phenyl)prop-2-enoate
1-[5-(2,6-dimethyl-1,2,4a,5,6,7,8,8a-octahydronaphthalene-1-carbonyl)-4,6-dihydroxypyridin-3-yl]-3-methoxycyclohexane-1,2,4-triol
(2s,3ar,6r,7ar)-1-[(2r)-2-{[(2s)-1,2-dihydroxy-3-(4-hydroxyphenyl)propylidene]amino}-4-methylpentanoyl]-6-hydroxy-octahydroindole-2-carboximidic acid
(2r)-n-[(1s,7s,9z,11e,13s,15r,19r)-7,13-dihydroxy-1,4,10,19-tetramethyl-17,18-dioxo-16-oxabicyclo[13.2.2]nonadeca-3,5,9,11-tetraen-2-yl]-2-hydroxypropanimidic acid
2,13'-dihydroxy-4',4',7,7,11'-pentamethyl-9',14'-diazaspiro[chromeno[5,6-b]pyrrole-3,5'-tetracyclo[5.5.2.0¹,⁹.0³,⁷]tetradecan]-13'-en-10'-one
(2r)-n-[(1s,3z,5z,7s,9e,11z,13s,15r,19r)-7,13-dihydroxy-1,4,10,19-tetramethyl-17,18-dioxo-16-oxabicyclo[13.2.2]nonadeca-3,5,9,11-tetraen-2-yl]-2-hydroxypropanimidic acid
(1r,2s,17s,20r)-2,27-dihydroxy-9,9,16,16-tetramethyl-8-oxa-14,24,26-triazaheptacyclo[18.5.2.0¹,¹⁷.0³,¹⁵.0⁴,¹³.0⁷,¹².0²⁰,²⁴]heptacosa-3(15),4,6,10,12,26-hexaen-25-one
(2r,3ar,6r,7ar)-1-[(2r)-2-{[(2s)-1,2-dihydroxy-3-(4-hydroxyphenyl)propylidene]amino}-4-methylpentanoyl]-6-hydroxy-octahydroindole-2-carboximidic acid
(1'r,3r,3's,7's,11'r)-2,13'-dihydroxy-4',4',7,7,11'-pentamethyl-9',14'-diazaspiro[chromeno[5,6-b]pyrrole-3,5'-tetracyclo[5.5.2.0¹,⁹.0³,⁷]tetradecan]-13'-en-10'-one
19-methoxy-14,14,21,21-tetramethyl-22-oxa-5,11,16-triazahexacyclo[13.11.0.0³,¹¹.0⁵,⁹.0¹⁷,²⁶.0¹⁸,²³]hexacosa-1(15),8,12,17,23,25-hexaene-4,10-dione
n-{8,14-dihydroxy-5,11,19,20-tetramethyl-18-oxo-2,17-dioxabicyclo[14.3.1]icosa-1(19),4,6,10,12-pentaen-3-yl}-2-hydroxypropanimidic acid
(3s)-19-methoxy-14,14,21,21-tetramethyl-22-oxa-5,11,16-triazahexacyclo[13.11.0.0³,¹¹.0⁵,⁹.0¹⁷,²⁶.0¹⁸,²³]hexacosa-1(15),8,12,17,23,25-hexaene-4,10-dione
2,27-dihydroxy-9,9,16,16-tetramethyl-8-oxa-14,24,26-triazaheptacyclo[18.5.2.0¹,¹⁷.0³,¹⁵.0⁴,¹³.0⁷,¹².0²⁰,²⁴]heptacosa-3(15),4,6,10,12,26-hexaen-25-one
(1s,8s,10s,11r,12s,13s)-3-hydroxy-4,11,12-trimethoxy-17-methyl-18-oxa-17-azapentacyclo[8.4.3.1⁸,¹¹.0¹,¹⁰.0²,⁷]octadeca-2,4,6-trien-13-yl (2s)-2-methylbutanoate
(5z)-13-{[3,4-dihydroxy-4,6-dimethyl-5-(methylamino)oxan-2-yl]oxy}-8-methoxy-5-propylidene-3,9-diazatricyclo[8.4.0.0³,⁷]tetradeca-1(14),10,12-trien-2-one
(1r,2s,17s,19s)-26-hydroxy-2-methoxy-9,9,16,16-tetramethyl-8-oxa-14,23,25-triazaheptacyclo[17.5.2.0¹,¹⁷.0³,¹⁵.0⁴,¹³.0⁷,¹².0¹⁹,²³]hexacosa-3(15),4,6,10,12,25-hexaen-24-one
(1r,2s,3r,4s)-1-{5-[(1s,2s,4ar,6s,8as)-2,6-dimethyl-1,2,4a,5,6,7,8,8a-octahydronaphthalene-1-carbonyl]-4,6-dihydroxypyridin-3-yl}-3-methoxycyclohexane-1,2,4-triol
(5z,7s,8s)-13-{[(2s,3s,4r,5s,6r)-3,4-dihydroxy-4,6-dimethyl-5-(methylamino)oxan-2-yl]oxy}-8-methoxy-5-propylidene-3,9-diazatricyclo[8.4.0.0³,⁷]tetradeca-1(14),10,12-trien-2-one
(1s,9ar)-octahydro-1h-quinolizin-1-ylmethyl (2z)-3-(4-{[(2s,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}phenyl)prop-2-enoate
(2r,5e)-7-hydroxy-2-[(4r)-1-(2-hydroxy-4-{[(2s,3r,4s,5r)-3,4,5-trihydroxyoxan-2-yl]oxy}butyl)-2-iminoimidazolidin-4-yl]-6-methylhept-5-enoic acid
(2s,3as,6r,7as)-1-(2-{[(2r)-1,2-dihydroxy-3-(4-hydroxyphenyl)propylidene]amino}-4-methylpentanoyl)-6-hydroxy-octahydroindole-2-carboximidic acid
LPE(17:3)
Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved